Tetra Radar · FDA Approvals · Decision date
Liquidia Corporation: FDA decision date
Liquidia Corporation (LQDA) · 24 June 2027
In August 2026, the FDA accepted the NDA for ralinepag to treat PAH and set a PDUFA target action date of June 24, 2027.
Source: 10-Q of 10 November 2026
The decision is pending.
Liquidia Corporation on Tetra Radar
A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.